Type 2 diabetes with partial lipodystrophy of the limbs: A new lipodystrophy phenotype

Diabetes Care

Volumn 36, Issue 8, 2013, Pages 2247-2253

  Strickland, Leah R ^a,b   Guo, Fangjian ^a   Lok, Kerry ^a   Garvey, W Timothy ^a,c  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^c BIRMINGHAM VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; CHOLESTEROL; INSULIN; METFORMIN; SULFONYLUREA; TRIACYLGLYCEROL; GLUCOSE;

ACANTHOSIS NIGRICANS; ADULT; AGE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BODY MASS; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL EVALUATION; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE SEVERITY; ETHNICITY; FEMALE; FOREARM; GENDER; GLUCONEOGENESIS; GLUCOSE CLAMP TECHNIQUE; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HUMAN; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; LEG; LIPODYSTROPHY; NON INSULIN DEPENDENT DIABETES MELLITUS; PARTIAL LIMB LIPODYSTROPHY; PHENOTYPE; SUBCUTANEOUS FAT; TRIACYLGLYCEROL BLOOD LEVEL; COMPLICATION; METABOLISM; MIDDLE AGED; PATHOLOGY;

ACANTHOSIS NIGRICANS; ADULT; DIABETES MELLITUS, TYPE 2; FEMALE; FOREARM; GLUCOSE; HUMANS; INSULIN; INSULIN RESISTANCE; LEG; LIPODYSTROPHY; MIDDLE AGED;

EID: 84886044158     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc12-1529     Document Type: Article

References (28)

1. Garg A. Lipodystrophies. Am JMed 2000; 108:143-152
2. Garg A. Acquired and inherited lipodystrophies. N Engl J Med 2004;350: 1220-1234
3. Garg A, Agarwal AK. Lipodystrophies: disorders of adipose tissue biology. Biochim Biophys Acta 2009;1791:507-513
4. Garg A. Lipodystrophies: genetic and acquired body fat disorders. J Clin Endocrinol Metab 2011;96:3313-3325
5. Chan JL, Oral EA. Clinical classification and treatment of congenital and acquired lipodystrophy. Endocr Pract 2010;16:310-323
6. DeFronzo RA. Dysfunctional fat cells, lipotoxicity and type 2 diabetes. Int J Clin Pract Suppl 2004;Oct:9-21
7. Boden G. Obesity, insulin resistance and free fatty acids. Curr Opin Endocrinol Diabetes Obes 2011;18:139-143
8. Adiels M, Olofsson SO, Taskinen MR, Borén J. Overproduction of very lowdensity lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome. Arterioscler Thromb Vasc Biol 2008;28: 1225-1236
9. Forouhi NG, Jenkinson G, Thomas EL, et al. Relation of triglyceride stores in skeletal muscle cells to central obesity and insulin sensitivity in European and South Asian men. Diabetologia 1999;42:932-935
10. McGarry JD. Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes 2002; 51:7-18
11. Yki-Järvinen H. Liver fat in the pathogenesis of insulin resistance and type 2 diabetes. Dig Dis 2010;28:203-209
12. Dyck DJ, Heigenhauser GJ, Bruce CR. The role of adipokines as regulators of skeletal muscle fatty acid metabolism and insulin sensitivity. Acta Physiol (Oxf) 2006;186: 5-16
13. Kim JK, Gavrilova O, Chen Y, Reitman ML, Shulman GI. Mechanism of insulin resistance in A-ZIP/F-1 fatless mice. J Biol Chem 2000;275:8456-8460
14. Agarwal AK, Sukumaran S, Cortés VA, et al. Human 1-acylglycerol-3-phosphate O-acyltransferase isoforms 1 and 2: biochemical characterization and inability to rescue hepatic steatosis in Agpat2(-/-) gene lipodystrophic mice. J Biol Chem 2011;286:37676-37691
15. Frayn KN. Adipose tissue as a buffer for daily lipid flux. Diabetologia 2002;45: 1201-1210
16. Varma V, Yao-Borengasser A, Rasouli N, et al. Muscle inflammatory response and insulin resistance: synergistic interaction between macrophages and fatty acids leads to impaired insulin action. Am J Physiol Endocrinol Metab 2009;296: E1300-E1310
17. Bhargava P, Lee CH. Role and function of macrophages in the metabolic syndrome. Biochem J 2012;442:253-262
18. Herrero L, Shapiro H, Nayer A, Lee J, Shoelson SE. Inflammation and adipose tissue macrophages in lipodystrophic mice. Proc Natl Acad Sci U S A 2010;107: 240-245
19. Garvey WT, Olefsky JM, Griffin J, Hamman RF, KoltermanOG. The effect of insulin treatment on insulin secretion and insulin action in type II diabetes mellitus. Diabetes 1985;34:222-234
20. Gottesman I, Mandarino L, Gerich J. Estimation and kinetic analysis of insulinindependent glucose uptake in human subjects. Am J Physiol 1983;244:E632-E635
21. Jumpertz R, Thearle MS, Bunt JC, Krakoff J. Assessment of non-insulin-mediated glucose uptake: association with body fat and glycemic status. Metabolism 2010;59: 1396-1401
22. Herbst KL, Tannock LR, Deeb SS, Purnell JQ, Brunzell JD, Chait A. Köbberling type of familial partial lipodystrophy: an underrecognized syndrome. Diabetes Care 2003;26:1819-1824
23. Decaudain A, Vantyghem MC, Guerci B, et al. New metabolic phenotypes in laminopathies: LMNA mutations in patients with severe metabolic syndrome. J Clin Endocrinol Metab 2007;92:4835-4844
24. Visser ME, Kropman E, Kranendonk ME, et al. Characterisation of non-obese diabetic patients with marked insulin resistance identifies a novel familial partial lipodystrophy-associated PPARg mutation (Y151C). Diabetologia 2011;54: 1639-1644
25. Simha V, Garg A. Inherited lipodystrophies and hypertriglyceridemia. Curr Opin Lipidol 2009;20:300-308
26. Oral EA, Chan JL. Rationale for leptinreplacement therapy for severe lipodystrophy. Endocr Pract 2010;16:324-333
27. Chong AY, Lupsa BC, Cochran EK, Gorden P. Efficacy of leptin therapy in the different forms of human lipodystrophy. Diabetologia 2010;53:27-35
28. Simha V, SubramanyamL, Szczepaniak L, et al. Comparison of efficacy and safety of leptin replacement therapy in moderately and severely hypoleptinemic patientswith familial partial lipodystrophy of the Dunnigan variety. J Clin Endocrinol Metab 2012;97:785-792